# Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Study · id `cardio:ct-nct03470545` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03470545](<https://clinicaltrials.gov/study/NCT03470545>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT03470545

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.

## Technical summary

Registry record NCT03470545. Randomized; quadruple masking; primary purpose treatment. Start 2018-05-29 (actual); primary completion 2020-03-14 (actual). Results posted on 2021-10-04.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 251 participants (enrolled count; ClinicalTrials.gov record NCT03470545, source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)
- Started: 2018-05-29 (actual) (ClinicalTrials.gov record NCT03470545, source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)
- Primary completion: 2020-03-14 (actual) (ClinicalTrials.gov record NCT03470545, source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)
- Completion: 2020-05-06 (actual) (ClinicalTrials.gov record NCT03470545, source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)
- Results first posted: 2021-10-04 (ClinicalTrials.gov record NCT03470545, source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)
- Countries: United States; Belgium; Czechia; Denmark; France; Germany; Israel; Italy; Netherlands; Poland; Portugal; Spain; United Kingdom (ClinicalTrials.gov record NCT03470545, source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03470545-2021-10-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
- Acronym: EXPLORER-HCM
- Condition: Obstructive Hypertrophic Cardiomyopathy
- Intervention (Drug): mavacamten
- Intervention (Drug): Placebo
- Lead sponsor: MyoKardia, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Hypertrophic cardiomyopathy (`cardio:hypertrophic-cardiomyopathy`)
- Registry intervention name matches this record: Mavacamten (`cardio:mavacamten`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial (`cardio:pubmed-32871100`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial (`cardio:pubmed-34004177`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Mavacamten on Echocardiographic Features in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy (`cardio:pubmed-34915982`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Assessing health-related quality-of-life in patients with symptomatic obstructive hypertrophic cardiomyopathy: EQ-5D-based utilities in the EXPLORER-HCM trial (`cardio:pubmed-34907813`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effects of Mavacamten on Measures of Cardiopulmonary Exercise Testing Beyond Peak Oxygen Consumption: A Secondary Analysis of the EXPLORER-HCM Randomized Trial (`cardio:pubmed-36652223`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Kansas City Cardiomyopathy Questionnaire in Relation to New York Heart Association Class (`cardio:pubmed-39349158`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy (`cardio:pubmed-39349160`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Association Between age or Duration of Diagnosis in Obstructive Hypertrophic Cardiomyopathy and Response to Mavacamten Treatment: Exploratory Analysis of the EXPLORER-HCM Trial (`cardio:pubmed-39653325`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 846e2466d7b01ced40d93a20436201a13d7f43868dc8c9243c0339cb11bd9a00
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
